Biostar Pharmaceuticals, Inc.
BSPM · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$125 | -$1,314 | -$1,014 | $3,388 |
| Dep. & Amort. | $300 | $282 | $298 | $229 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$164 | $5,558 | $1,054 | $5,998 |
| Other Non-Cash | -$13 | -$259 | -$17 | -$5,614 |
| Operating Cash Flow | -$1 | $4,266 | $321 | $4,002 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | -$44 | -$4 | $0 | -$6 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$44 | $0 | $0 | $0 |
| Investing Cash Flow | -$44 | -$4,364 | $0 | -$6,378 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $3 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1,690 |
| Financing Cash Flow | $0 | $0 | $0 | $1,692 |
| Forex Effect | $3 | $21 | -$11 | $198 |
| Net Chg. in Cash | -$42 | -$76 | $311 | -$486 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $407 | $484 | $173 | $659 |
| End Cash | $365 | $407 | $484 | $173 |
| Free Cash Flow | -$1 | $4,266 | $321 | $4,002 |